Product correctly added to cart.

discount label
ONO-8590580
View 3D

Biosynth logo

ONO-8590580

CAS: 1802661-73-9

Ref. 3D-CXC66173

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Thursday 9 Jan 2025

Product Information

Name:
ONO-8590580
Description:

ONO-8590580 is a potentiator of cholinergic neurotransmission. It binds to the acetylcholine binding site of alpha7 nicotinic receptor subunit, and the activation of this receptor enhances acetylcholine release in hippocampal cells. ONO-8590580 has been shown to be an allosteric modulator of alpha7 nicotinic receptors, which may lead to increased levels of acetylcholine in the brain. This drug also inhibits benzodiazepine binding, which may contribute to its cognitive enhancement effects. It has been shown that ONO-8590580 can increase the expression of wild type mice and is optimised for oral use. The drug is currently in phase I clinical trials for Alzheimer's disease and other neurodegenerative disorders.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
376.43 g/mol
Formula:
C21H21FN6
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-CXC66173 ONO-8590580

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".